FDA recall, , Moderate risk
American National Red Cross Blood Components
American National Red Cross Blood Components, collected in a manner that compromises the sterility of the collection system, were distributed.
Recall ended Mar 23, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
American National Red Cross, Penn Jersey Region, recalled Red Blood Cells, PF24 Plasma, Whole Blood, Apheresis Fresh Frozen Plasma, Pooled Cryoprecipitated AHF, Apheresis Red Blood Cells, and Cryoprecipitated AHF because they were collected in a manner that compromises the sterility of the collection system.
The recall began April 3, 2024, and was added to the FDA's Enforcement Report on March 23, 2026. The products were distributed in Illinois, Maryland, North Carolina, New Jersey, New York, Ohio, Oregon, Pennsylvania, South Carolina, Texas, Virginia, West Virginia, District of Columbia and Puerto Rico.
4 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
9 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, collected in a manner that compromises the sterility of the collection system, were distributed.
PF24 Plasma
Reason: PF24 Plasma, collected in a manner that compromises the sterility of the collection system, were distributed.
Whole Blood, Leukocytes Reduced
Reason: Whole Blood, Leukocytes Reduced, collected in a manner that compromises the sterility of the collection system, were distributed.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected in a manner that compromises the sterility of the collection system, were distributed.
Apheresis Fresh Frozen Plasma
Reason: Apheresis Fresh Frozen Plasma, collected in a manner that compromises the sterility of the collection system, were distributed.
- Affected units
- W202223017843007 (triple collection); W20222300509900T (triple collection)
Pooled Cryoprecipitated AHF
Reason: Pooled Cryoprecipitated AHF, collected in a manner that compromises the sterility of the collection system, were distributed.
Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, collected in a manner that compromises the sterility of the collection system, were distributed.
Cryoprecipitated AHF
Reason: Cryoprecipitated AHF, collected in a manner that compromises the sterility of the collection system, were distributed.
Apheresis Red Blood Cells, Leukocytes Reduced
Reason: Apheresis Red Blood Cells, Leukocytes Reduced, collected in a manner that compromises the sterility of the collection system, were distributed.
- Affected units
- W18222401887500S (double collection); W18222400464100C (double collection); W18222400932200* (double collection); W18222401471200J; W182224015028006; W182224018827007 (double collection); W182224004727000 (double collection); W18222401001300Q; W182224018844005 (double collection); W18222402676700* (double collection); W18222402771900* (double collection); W20222303429300J (double collection); W18222403239400K (double collection); W182224032406007 (double collection)
Recall details
- Company began the recall
- Sold in
- 12 states, DC and Puerto Rico
- Company
- American National Red Cross, Penn Jersey Region
- Hazard
- Sterility problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98450
- Recall numbers
- B-0031-2026 to B-0039-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
